Cold Atmospheric Plasma, Platelet-Rich Plasma, and Nitric Oxide Synthesis Inhibitor: Effects Investigation on an Experimental Model on Rats
Authors:
- Bogdan CabaBCBogdan Caba
- Ioannis GardikiotisIGIoannis Gardikiotis
- Ionut TopalaIonut Topala
- Ilarion MihailaIMIlarion Mihaila
- Cosmin Teodor MihaiCMCosmin Teodor Mihai
- Catalina LucaCatalina Luca
- Sorin PascaSPSorin Pasca
- Ioana Cezara CabaIoana Cezara Caba
- Gabriel DimitriuGDGabriel Dimitriu
- Bogdan HuzumBHBogdan Huzum
- Ionela Lacramioara SerbanIonela Lacramioara Serban
Open Access
- 7 January 2022
- journal article
- research article
- Published by MDPI AG in Applied Sciences
- Vol. 12 (2) , 590
Abstract
The evolution of reconstructive methods for defects of the human body cannot yet replace the use of flap surgery. Research is still preoccupied with the ideal techniques for offering the best chances of survival of the flaps. In our study, we investigated the effects of cold atmospheric plasma (CAP), N-nitro-L-arginine methyl ester (L-NAME), and platelet-rich plasma (PRP) injectable solutions on flap survival using an in vivo model. Twenty-four Wistar rats (four groups) had the McFarlane flap raised and CAP, L-NAME, and PRP substances tested through a single dose subcutaneous injection. The control group had only a saline solution injected. To the best of our knowledge, this is the first study that evaluated a CAP activated solution through injection on flaps. The flap survival rate was determined by clinical examination (photography documented), hematology, thermography, and anatomopathological tests. The image digital analysis performed on the flaps showed that the necrosis area (control—49.64%) was significantly lower for the groups with the three investigated solutions: CAP (14.47%), L-NAME (18.2%), and PRP (23.85%). Thermography exploration revealed less ischemia than the control group on the CAP, L-NAME, and PRP groups as well. Anatomopathological data noted the best degree of angiogenesis on the CAP group, with similar findings on the L-NAME and PRP treated flaps. The blood work did not indicate infection or a strong inflammatory process in any of the subjects. Overall, the study shows that the CAP activated solution has a similar (better) impact on the necrosis rate (compared with other solutions with known effects) when injected on the modified dorsal rat skin flap, and on top of that it can be obtained fast, in unlimited quantities, non-invasively, and through a standardized process.Keywords
This publication has 47 references indexed in Scilit:
- Effect of Side-Stream Smoking on Random-Pattern Skin Flap Survival in RatsAnnals of Plastic Surgery, 2014
- L-NAME in the cardiovascular system – nitric oxide synthase activator?Pharmacological Reports, 2012
- Subcutaneous Injections of Platelet-Rich Plasma into Skin Flaps Modulate Proangiogenic Gene Expression and Improve Survival RatesPlastic and Reconstructive Surgery, 2012
- Bacterial Inactivation in Liquids Using Multi-Gas PlasmasPlasma Medicine, 2012
- Chronic Lithium Impairs Skin Tolerance to Ischemia in Random-Pattern Skin Flap of RatsJournal of Surgical Research, 2011
- PRP&F/P MPs Improved Survival of Dorsal Paired Pedicle Skin Flaps in RatsJournal of Surgical Research, 2011
- Effects of nitric oxide synthase inhibition on blood flow and survival in experimental skin flapsJournal of Plastic, Reconstructive & Aesthetic Surgery, 2006
- An ameliorated skin flap model in rats for experimental researchJournal of Plastic, Reconstructive & Aesthetic Surgery, 2006
- Secondary ischemic tolerance improved by administration of L-NAME in rat flapsMicrosurgery, 1996
- Nitric oxide synthase inhibitors improve skin flap survival in the ratMicrosurgery, 1994